Advertisements



Valeant Pharmaceuticals: Intrigued…Really?

Deutsche Bank analyst Gregg Gilbert is warming up the the controversial drug maker. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

Valeant"s CEO Details The Company"s "Great Progress" And What"s Next

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) peaked north of $250 per share in 2015, but by 2017 they dropped to a single digit. Needless to say, this represented a challenging time for the company. read more.....»»

Category: blogSource: benzingaAug 17th, 2017

Valeant Pharmaceuticals CEO: "It"s been a challenging 15 months, but we"ve made great progress"

Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround......»»

Category: topSource: madmoneyAug 16th, 2017

Valeant Pharma works to resolve FDA concerns at Tampa plant

Valeant Pharmaceuticals International Inc. shares ticked higher in the extended session Wednesday after the drugmaker said that issues from a Food and Drug Administration inspection were being resolved. Valeant shares rose 1% to $1.....»»

Category: topSource: marketwatchAug 16th, 2017

The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak

InvestorPlace - Stock Market News, Stock Advice .....»»

Category: topSource: investorplaceAug 16th, 2017

13D Filing: Paulson & Co and Valeant Pharmaceuticals International Inc. (VRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 5 – SEC Filing SECURITIES AND EXCHANGE COMMIS.....»»

Category: topSource: insidermonkeyAug 12th, 2017

There"s A Reason Valeant Pharmaceuticals Bulls Didn"t Stay Convinced

There"s A Reason Valeant Pharmaceuticals Bulls Didn"t Stay Convinced.....»»

Category: topSource: seekingalphaAug 10th, 2017

Valeant Pharmaceuticals: A Lesson In Value Traps

Valeant Pharmaceuticals: A Lesson In Value Traps.....»»

Category: topSource: seekingalphaAug 10th, 2017

Earnings Hangover Sacks Valeant Pharmaceuticals" Stock, Sending Shares Down 10%

What happ.....»»

Category: futuresSource: nasdaqAug 9th, 2017

Valeant Isn"t Out Of The Woods Yet

Investors initially celebrated a mixed Q2 earnings report from Valeant Pharmaceuticals Intl Inc (NYSE: VRX) to the tune of a 7 percent Tuesday-morning pop for the stock. Latest Ratings for VRX .....»»

Category: blogSource: benzingaAug 9th, 2017

What A Difference 24 Hours Makes For Valeant

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares initially jumped more than 7 percent following the company’s second-quarter earnings report. read more.....»»

Category: blogSource: benzingaAug 9th, 2017

Valeant's Top Drug Is Growing Again, Offsetting Wider Slump - Bloomberg

BloombergValeant's Top Drug Is Growing Again, Offsetting Wider SlumpBloombergValeant Pharmaceuticals International Inc.'s most important drug is showing signs of getting back on trac.....»»

Category: topSource: googlenewsAug 8th, 2017

Valeant Pharmaceuticals: Bears Will Be Bears

Valeant's earnings today have done little to change the minds of bulls or bears......»»

Category: blogSource: barronsAug 8th, 2017

Valeant is done selling off units to pay down debt, CEO says

The CEO of Valeant Pharmaceuticals International Inc. said the drugmaker has slimmed down enough for now and will focus on generating cash from its remaining businesses as it pays down a mountain of debt......»»

Category: topSource: moneycentralAug 8th, 2017

Valeant Pharmaceuticals International (VRX) Q2 2017 Results - Earnings Call Transcript

Valeant Pharmaceuticals International (VRX) Q2 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 8th, 2017

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday......»»

Category: blogSource: 247wallstAug 8th, 2017

Is Now The Time To Buy Valeant Pharmaceuticals?

Is Now The Time To Buy Valeant Pharmaceuticals?.....»»

Category: topSource: seekingalphaAug 8th, 2017

Valeant Pharmaceuticals Intl Inc (VRX) Stock Scores 2 Vital Victories

InvestorPlace - Stock Market News, Stock Advice & Trading Ti.....»»

Category: topSource: investorplaceAug 8th, 2017

Valeant narrows loss, expects to cut debt

Valeant Pharmaceuticals International Inc. (VRX) on Tuesday reported a loss of $38 million in its second quarter......»»

Category: topSource: foxnewsAug 8th, 2017

Tuesday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (AAPL) increases its focus on India.....»»

Category: topSource: investorplaceAug 8th, 2017

Valeant Pharmaceuticals Intl Inc Q2 2017 Earnings Boost Shares

Valeant Pharmaceuticals Q2 2017 earnings were released before opening bell this morning.....»»

Category: blogSource: valuewalkAug 8th, 2017